Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

New Market Research Report: Savient Pharmaceuticals Inc - SWOT, Strategy and Corporate Finance Report


Print article Print article
2013-12-23 18:33:43 - New Business market report from MarketLine: "Savient Pharmaceuticals Inc - SWOT, Strategy and Corporate Finance Report"

Savient Pharmaceuticals Inc - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360deg view of the company.

Features:

* Detailed information on Savient Pharmaceuticals Inc required for business and competitor intelligence needs
* A study of the major internal and external factors affecting Savient Pharmaceuticals Inc in the form of a SWOT analysis
* An in-depth view of the business model of Savient Pharmaceuticals Inc including a breakdown and examination of key business segments
* Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios

for Savient Pharmaceuticals Inc
* Intelligence on Savient Pharmaceuticals Incnv's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
* News about Savient Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins
* Large number of easy-to-grasp charts and graphs that present important data and key trends

Full Report Details at
- www.fastmr.com/prod/757479_savient_pharmaceuticals_inc_swot_stra ..

Highlights:

Savient Pharmaceuticals, Inc. (Savient or 'the company') is a specialty biopharmaceutical company engaged in developing Krystexxa (pegloticase) for the treatment of refractory chronic gout. It also manufactures and supplies Oxandrin (oxandrolone) in the US. It is headquartered in East Brunswick, New Jersey and employed 122 people as of March 18, 2013. The company recorded revenues of $18 million during the financial year ended December 2012 (FY2012), an increase of 87.5% over FY2011. The operating loss of the company was $119 million during FY2012, as compared to an operating loss of $115 million during FY2011. The net loss was $118 million in FY2012, as compared to a net loss of $102 million in FY2011.

Reasons to Purchase:

* Gain understanding of Savient Pharmaceuticals Inc and the factors that influence its strategies
* Track strategic initiatives of the company and latest corporate news and actions
* Assess Savient Pharmaceuticals Inc as a prospective partner, vendor or supplier
* Support sales activities by understanding your customers' businesses better
* Stay up to date on Savient Pharmaceuticals Inc's business structure, strategy and prospects

Partial Table of Contents:

Company Snapshot
Savient Pharmaceuticals Inc: Company Overview
Savient Pharmaceuticals Inc: Overview and Key Facts
Savient Pharmaceuticals Inc: Overview
Savient Pharmaceuticals Inc: Key Facts
Savient Pharmaceuticals Inc: Key Employees
Savient Pharmaceuticals Inc: Key Employee Biographies
Savient Pharmaceuticals Inc: Major Products and Services
Savient Pharmaceuticals Inc: Company History
Savient Pharmaceuticals Inc: Management Statement
Savient Pharmaceuticals Inc: Locations and Subsidiaries
Savient Pharmaceuticals Inc: Key Competitors
Savient Pharmaceuticals Inc: Company Analysis
Savient Pharmaceuticals Inc: Business Description
Savient Pharmaceuticals Inc: SWOT Analysis
Savient Pharmaceuticals Inc: SWOT Overview
Savient Pharmaceuticals Inc: Strengths
Savient Pharmaceuticals Inc: Weaknesses
Savient Pharmaceuticals Inc: Opportunities
Savient Pharmaceuticals Inc: Threats
Savient Pharmaceuticals Inc: Corporate Financial Deals Activity
Savient Pharmaceuticals Inc: Financial Deals Overview
Savient Pharmaceuticals Inc: Targets and Partners
Savient Pharmaceuticals Inc: Top Deals 2009 - 2013YTD*
Savient Pharmaceuticals Inc: Advisors
Savient Pharmaceuticals Inc: Top Legal Advisors
Savient Pharmaceuticals Inc: Top Financial Advisors
Savient Pharmaceuticals Inc: Capital Raising
Savient Pharmaceuticals Inc: Partnership
Savient Pharmaceuticals Inc: Divestments
Savient Pharmaceuticals Inc: Recent Developments
Savient Pharmaceuticals Inc: News and Events Summary
Savient Pharmaceuticals Inc: Business Expansion
Savient Pharmaceuticals Inc: Corporate Governance
Savient Pharmaceuticals Inc: Financial Performance
Savient Pharmaceuticals Inc: Regulatory and Legal Events
Savient Pharmaceuticals Inc: Research & Development
Appendix
Contact Us
Methodology
Definitions
About Datamonitor

List of Tables

Table 1: Savient Pharmaceuticals Inc: Key Facts
Table 2: Savient Pharmaceuticals Inc: Key Employees
Table 4: Savient Pharmaceuticals Inc: Key Competitors
Table 5: Savient Pharmaceuticals Inc: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Savient Pharmaceuticals Inc: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 7: Savient Pharmaceuticals Inc: Targets and Partners
Table 8: Savient Pharmaceuticals Inc: Top Deals 2009 - 2013YTD*
Table 9: Savient Pharmaceuticals Inc: Legal Advisor Ranking by Value (US$m)
Table 10: Savient Pharmaceuticals Inc: Financial Advisor Ranking by Value (US$m)
Table 11: Savient Pharmaceuticals Inc: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Table 12: Savient Pharmaceuticals Inc: Capital Raising by Deal Type (2009 - YTD*2013)
Table 13: Savient Pharmaceuticals Inc: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 14: Savient Pharmaceuticals Inc: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 15: Savient Pharmaceuticals Inc: Divestments Volume and Value Trend (2009 - YTD*2013)
Table 16: Savient Pharmaceuticals Inc: Divestments by Geography (2009 - YTD*2013)
Table 17: Savient Pharmaceuticals Inc: News and Events Summary
Table 18: Savient Pharmaceuticals Inc: Business Expansion
Table 19: Savient Pharmaceuticals Inc: Corporate Governance

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=757479&dt=t

About MarketLine

MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at www.fastmr.com/catalog/publishers.aspx?pubid=1034

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser